Close this search box.

Give Your Patients Peace of Mind with the SRT-100™ for Basal Cell Carcinoma Treatment

January 19, 2016

Patients who are diagnosed with basal cell carcinomas have a number of treatment options available. As a physician, you are well aware that most of those options involve surgery of some sort — an unsettling and intimidating option for patients.

What if you could provide your patients with a non-surgical basal cell carcinoma treatment option with cure rates comparable to those of surgical basal cell carcinoma treatment options?

With Sensus Healthcare’s SRT-100™, you can.

Superficial Radio Therapy is the non-surgical choice in basal cell carcinoma treatment options. It can also be used to remove keloid scarring. This treatment method is safe and effective and involves no cutting, bleeding, or stitching. With the SRT-100™, there is no need for anesthesia, no risk of infection or scarring, and no need for reconstructive plastic surgery due to unsightly scarring after surgery.

The SRT-100™ delivers a precise, calibrated dose of Superficial Radio Therapy directly to the skin, effectively destroying basal cell carcinomas. Patients who undergo treatment with the SRT-100™ heal quickly, with no downtime or lifestyle restrictions following treatment. It is ideal for patients with health risks that prevent them from undergoing surgical treatment, or patients who wish to avoid the pain and scarring associated with surgery.

The SRT-100™ has many unique features making it a comfortable and effective basal cell carcinoma treatment option for patients and physicians. These features include broad range of motion; compact, mobile design, precise and accurate x-ray delivery; variable applicator sizes; and replaceable contact shields.

Sensus Healthcare’s SRT-100™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare providers.

Are you ready to offer your patients a new, non-surgical, painless, and effective treatment for their basal cell carcinomas? Contact Sensus Healthcare today to learn more about the SRT-100™ and how it can help your practice.